Table 1. Summary of study subjects.
Animal # | ROA | Vector | Dose | Weight (kg) | Sex | Age |
---|---|---|---|---|---|---|
17 | CM | AAV9.CMV.eGFP | 5 × 1012 GC/kg | 3.60 | F | 8 years |
18 | CM | AAV9.CB7.eGFP | 5 × 1012 GC/kg | 3.85 | F | 8 years |
20 | CM | AAV9.CB7.eGFP | 2.5 × 1012 GC/kg | 5.40 | F | 8 years |
21 | CM | AAV9.CB7.eGFP | 2.5 × 1012 GC/kg | 8.75 | F | 8 years |
04 | L | AAV9.CB7.eGFP | 2.5 × 1012 GC/kg | 4.25 | F | 8 years |
05 | L | AAV9.CB7.eGFP | 2.5 × 1012 GC/kg | 4.85 | F | 8 years |
49 | IV | AAV9.CMV.eGFP | 2.0 × 1013 GC/kg | 3.30 | F | 8 years |
CM, cisterna magna; F, female; IV, intravenous; L, lumbar injection; ROA, route of administration.